HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-APR-21 7MFC TITLE CRYSTAL STRUCTURE OF CSF1R IN COMPLEX WITH VIMSELTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 542-919 WITH DELETION OF 696- COMPND 5 741; COMPND 6 SYNONYM: CSF-1 RECEPTOR,CSF-1-R,CSF-1R,M-CSF-R,PROTO-ONCOGENE C-FMS; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSF1R, FMS; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TNI; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: CID100239 KEYWDS CANCER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ABENDROTH,D.R.DAVIES,K.ATKINS REVDAT 2 18-OCT-23 7MFC 1 REMARK REVDAT 1 24-NOV-21 7MFC 0 JRNL AUTH B.D.SMITH,M.D.KAUFMAN,S.C.WISE,Y.M.AHN,T.M.CALDWELL, JRNL AUTH 2 C.B.LEARY,W.P.LU,G.TAN,L.VOGETI,S.VOGETI,B.A.WILKY, JRNL AUTH 3 L.E.DAVIS,M.SHARMA,R.RUIZ-SOTO,D.L.FLYNN JRNL TITL VIMSELTINIB: A PRECISION CSF1R THERAPY FOR TENOSYNOVIAL JRNL TITL 2 GIANT CELL TUMORS AND DISEASES PROMOTED BY MACROPHAGES. JRNL REF MOL.CANCER THER. V. 20 2098 2021 JRNL REFN ESSN 1538-8514 JRNL PMID 34433663 JRNL DOI 10.1158/1535-7163.MCT-21-0361 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11_2563 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 9224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.640 REMARK 3 FREE R VALUE TEST SET COUNT : 889 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.9800 - 2.8000 1.00 1348 144 0.2997 0.3688 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.670 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2243 REMARK 3 ANGLE : 0.584 3058 REMARK 3 CHIRALITY : 0.044 339 REMARK 3 PLANARITY : 0.006 394 REMARK 3 DIHEDRAL : 16.902 1299 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: NULL REMARK 3 ORIGIN FOR THE GROUP (A): 21.1954 -12.6176 -25.1645 REMARK 3 T TENSOR REMARK 3 T11: 0.3951 T22: 0.5133 REMARK 3 T33: 0.3263 T12: 0.0133 REMARK 3 T13: 0.0056 T23: 0.0410 REMARK 3 L TENSOR REMARK 3 L11: 4.4854 L22: 6.1564 REMARK 3 L33: 5.2113 L12: 0.4299 REMARK 3 L13: -0.0521 L23: 0.5114 REMARK 3 S TENSOR REMARK 3 S11: 0.0420 S12: 0.3478 S13: -0.1298 REMARK 3 S21: -0.1848 S22: -0.1074 S23: 0.4074 REMARK 3 S31: 0.1614 S32: -0.7704 S33: -0.0021 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: NULL REMARK 3 ORIGIN FOR THE GROUP (A): 28.6106 -12.3605 -1.5033 REMARK 3 T TENSOR REMARK 3 T11: 0.3263 T22: 0.3355 REMARK 3 T33: 0.2910 T12: -0.0753 REMARK 3 T13: -0.0045 T23: 0.0344 REMARK 3 L TENSOR REMARK 3 L11: 1.6385 L22: 1.7223 REMARK 3 L33: 2.3752 L12: -0.2958 REMARK 3 L13: -0.2811 L23: -0.1323 REMARK 3 S TENSOR REMARK 3 S11: 0.1129 S12: -0.1180 S13: -0.0740 REMARK 3 S21: -0.0137 S22: -0.0060 S23: 0.0071 REMARK 3 S31: -0.0765 S32: -0.2496 S33: -0.1028 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MFC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-21. REMARK 100 THE DEPOSITION ID IS D_1000256096. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE VERSION MAY 1, 2016 REMARK 200 BUILT=20160617 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9256 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.12800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.53400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2I1M CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CSF1R AT 4MG/ML WITH 0.5MM REMARK 280 VIMSELTINIB: CRYSTALLIZATION: 100MM TRIS BASE / HCL PH 7.71, 18% REMARK 280 PEG 8000, 100MM MGCL2: CRYO: 20% GLYCEROL, PH 7.50, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.87500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 30.93500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 30.93500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 136.31250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 30.93500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 30.93500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 45.43750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 30.93500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 30.93500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 136.31250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 30.93500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 30.93500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.43750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.87500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 531 REMARK 465 LYS A 532 REMARK 465 LYS A 533 REMARK 465 GLY A 534 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 465 HIS A 537 REMARK 465 HIS A 538 REMARK 465 HIS A 539 REMARK 465 HIS A 540 REMARK 465 GLY A 541 REMARK 465 GLN A 542 REMARK 465 LYS A 543 REMARK 465 PRO A 544 REMARK 465 LYS A 545 REMARK 465 TYR A 546 REMARK 465 GLN A 547 REMARK 465 VAL A 548 REMARK 465 ARG A 549 REMARK 465 TRP A 550 REMARK 465 LYS A 551 REMARK 465 ILE A 552 REMARK 465 ILE A 553 REMARK 465 GLU A 554 REMARK 465 SER A 555 REMARK 465 TYR A 556 REMARK 465 GLU A 557 REMARK 465 GLY A 558 REMARK 465 ASN A 559 REMARK 465 SER A 560 REMARK 465 TYR A 561 REMARK 465 THR A 562 REMARK 465 PHE A 563 REMARK 465 ILE A 564 REMARK 465 ASP A 565 REMARK 465 PRO A 566 REMARK 465 SER A 734 REMARK 465 PRO A 735 REMARK 465 GLY A 736 REMARK 465 GLN A 737 REMARK 465 ASP A 738 REMARK 465 PRO A 739 REMARK 465 GLU A 740 REMARK 465 GLY A 741 REMARK 465 LEU A 742 REMARK 465 ASP A 743 REMARK 465 LYS A 744 REMARK 465 GLU A 745 REMARK 465 ASP A 746 REMARK 465 GLY A 747 REMARK 465 ALA A 914 REMARK 465 GLN A 915 REMARK 465 GLU A 916 REMARK 465 ASP A 917 REMARK 465 ARG A 918 REMARK 465 ARG A 919 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 567 OG1 CG2 REMARK 470 GLN A 568 CG CD OE1 NE2 REMARK 470 LEU A 569 CG CD1 CD2 REMARK 470 LYS A 574 CG CD CE NZ REMARK 470 LYS A 586 CG CD CE NZ REMARK 470 LYS A 606 CG CD CE NZ REMARK 470 GLU A 607 CG CD OE1 OE2 REMARK 470 SER A 620 OG REMARK 470 THR A 621 OG1 CG2 REMARK 470 HIS A 623 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 627 CG CD CE NZ REMARK 470 GLU A 633 CG CD OE1 OE2 REMARK 470 LYS A 635 CG CD CE NZ REMARK 470 ILE A 636 CG1 CG2 CD1 REMARK 470 HIS A 639 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 678 CG CD CE NZ REMARK 470 LEU A 687 CG CD1 CD2 REMARK 470 ARG A 748 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 753 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 773 CG OD1 ND2 REMARK 470 LEU A 799 CG CD1 CD2 REMARK 470 LYS A 812 CG CD CE NZ REMARK 470 ASN A 814 CG OD1 ND2 REMARK 470 LYS A 867 CG CD CE NZ REMARK 470 LYS A 870 CG CD CE NZ REMARK 470 LYS A 883 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 621 82.60 -67.14 REMARK 500 PRO A 685 43.89 -58.34 REMARK 500 ASP A 778 55.86 -149.18 REMARK 500 THR A 787 -158.01 -121.31 REMARK 500 LYS A 812 44.23 -148.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Z6V A 1000 DBREF 7MFC A 542 919 UNP P07333 CSF1R_HUMAN 542 919 SEQADV 7MFC MET A 531 UNP P07333 INITIATING METHIONINE SEQADV 7MFC LYS A 532 UNP P07333 EXPRESSION TAG SEQADV 7MFC LYS A 533 UNP P07333 EXPRESSION TAG SEQADV 7MFC GLY A 534 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 535 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 536 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 537 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 538 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 539 UNP P07333 EXPRESSION TAG SEQADV 7MFC HIS A 540 UNP P07333 EXPRESSION TAG SEQADV 7MFC GLY A 541 UNP P07333 EXPRESSION TAG SEQADV 7MFC THR A 667 UNP P07333 CYS 667 ENGINEERED MUTATION SEQADV 7MFC A UNP P07333 GLY 696 DELETION SEQADV 7MFC A UNP P07333 VAL 697 DELETION SEQADV 7MFC A UNP P07333 ASP 698 DELETION SEQADV 7MFC A UNP P07333 TYR 699 DELETION SEQADV 7MFC A UNP P07333 LYS 700 DELETION SEQADV 7MFC A UNP P07333 ASN 701 DELETION SEQADV 7MFC A UNP P07333 ILE 702 DELETION SEQADV 7MFC A UNP P07333 HIS 703 DELETION SEQADV 7MFC A UNP P07333 LEU 704 DELETION SEQADV 7MFC A UNP P07333 GLU 705 DELETION SEQADV 7MFC A UNP P07333 LYS 706 DELETION SEQADV 7MFC A UNP P07333 LYS 707 DELETION SEQADV 7MFC A UNP P07333 TYR 708 DELETION SEQADV 7MFC A UNP P07333 VAL 709 DELETION SEQADV 7MFC A UNP P07333 ARG 710 DELETION SEQADV 7MFC A UNP P07333 ARG 711 DELETION SEQADV 7MFC A UNP P07333 ASP 712 DELETION SEQADV 7MFC A UNP P07333 SER 713 DELETION SEQADV 7MFC A UNP P07333 GLY 714 DELETION SEQADV 7MFC A UNP P07333 PHE 715 DELETION SEQADV 7MFC A UNP P07333 SER 716 DELETION SEQADV 7MFC A UNP P07333 SER 717 DELETION SEQADV 7MFC A UNP P07333 GLN 718 DELETION SEQADV 7MFC A UNP P07333 GLY 719 DELETION SEQADV 7MFC A UNP P07333 VAL 720 DELETION SEQADV 7MFC A UNP P07333 ASP 721 DELETION SEQADV 7MFC A UNP P07333 THR 722 DELETION SEQADV 7MFC A UNP P07333 TYR 723 DELETION SEQADV 7MFC A UNP P07333 VAL 724 DELETION SEQADV 7MFC A UNP P07333 GLU 725 DELETION SEQADV 7MFC A UNP P07333 MET 726 DELETION SEQADV 7MFC A UNP P07333 ARG 727 DELETION SEQADV 7MFC A UNP P07333 PRO 728 DELETION SEQADV 7MFC A UNP P07333 VAL 729 DELETION SEQADV 7MFC A UNP P07333 SER 730 DELETION SEQADV 7MFC A UNP P07333 THR 731 DELETION SEQADV 7MFC A UNP P07333 SER 732 DELETION SEQADV 7MFC A UNP P07333 SER 733 DELETION SEQADV 7MFC A UNP P07333 ASN 734 DELETION SEQADV 7MFC A UNP P07333 ASP 735 DELETION SEQADV 7MFC A UNP P07333 SER 736 DELETION SEQADV 7MFC A UNP P07333 PHE 737 DELETION SEQADV 7MFC A UNP P07333 SER 738 DELETION SEQADV 7MFC A UNP P07333 GLU 739 DELETION SEQADV 7MFC A UNP P07333 GLN 740 DELETION SEQADV 7MFC A UNP P07333 ASP 741 DELETION SEQADV 7MFC SER A 830 UNP P07333 CYS 830 ENGINEERED MUTATION SEQADV 7MFC THR A 907 UNP P07333 CYS 907 ENGINEERED MUTATION SEQRES 1 A 343 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY GLN LYS SEQRES 2 A 343 PRO LYS TYR GLN VAL ARG TRP LYS ILE ILE GLU SER TYR SEQRES 3 A 343 GLU GLY ASN SER TYR THR PHE ILE ASP PRO THR GLN LEU SEQRES 4 A 343 PRO TYR ASN GLU LYS TRP GLU PHE PRO ARG ASN ASN LEU SEQRES 5 A 343 GLN PHE GLY LYS THR LEU GLY ALA GLY ALA PHE GLY LYS SEQRES 6 A 343 VAL VAL GLU ALA THR ALA PHE GLY LEU GLY LYS GLU ASP SEQRES 7 A 343 ALA VAL LEU LYS VAL ALA VAL LYS MET LEU LYS SER THR SEQRES 8 A 343 ALA HIS ALA ASP GLU LYS GLU ALA LEU MET SER GLU LEU SEQRES 9 A 343 LYS ILE MET SER HIS LEU GLY GLN HIS GLU ASN ILE VAL SEQRES 10 A 343 ASN LEU LEU GLY ALA CYS THR HIS GLY GLY PRO VAL LEU SEQRES 11 A 343 VAL ILE THR GLU TYR CYS THR TYR GLY ASP LEU LEU ASN SEQRES 12 A 343 PHE LEU ARG ARG LYS ALA GLU ALA MET LEU GLY PRO SER SEQRES 13 A 343 LEU SER PRO GLY GLN ASP PRO GLU GLY LEU ASP LYS GLU SEQRES 14 A 343 ASP GLY ARG PRO LEU GLU LEU ARG ASP LEU LEU HIS PHE SEQRES 15 A 343 SER SER GLN VAL ALA GLN GLY MET ALA PHE LEU ALA SER SEQRES 16 A 343 LYS ASN CYS ILE HIS ARG ASP VAL ALA ALA ARG ASN VAL SEQRES 17 A 343 LEU LEU THR ASN GLY HIS VAL ALA LYS ILE GLY ASP PHE SEQRES 18 A 343 GLY LEU ALA ARG ASP ILE MET ASN ASP SER ASN TYR ILE SEQRES 19 A 343 VAL LYS GLY ASN ALA ARG LEU PRO VAL LYS TRP MET ALA SEQRES 20 A 343 PRO GLU SER ILE PHE ASP SER VAL TYR THR VAL GLN SER SEQRES 21 A 343 ASP VAL TRP SER TYR GLY ILE LEU LEU TRP GLU ILE PHE SEQRES 22 A 343 SER LEU GLY LEU ASN PRO TYR PRO GLY ILE LEU VAL ASN SEQRES 23 A 343 SER LYS PHE TYR LYS LEU VAL LYS ASP GLY TYR GLN MET SEQRES 24 A 343 ALA GLN PRO ALA PHE ALA PRO LYS ASN ILE TYR SER ILE SEQRES 25 A 343 MET GLN ALA CYS TRP ALA LEU GLU PRO THR HIS ARG PRO SEQRES 26 A 343 THR PHE GLN GLN ILE THR SER PHE LEU GLN GLU GLN ALA SEQRES 27 A 343 GLN GLU ASP ARG ARG HET Z6V A1000 32 HETNAM Z6V VIMSELTINIB HETSYN Z6V 3-METHYL-5-(6-METHYL-5-{[2-(1-METHYL-1H-PYRAZOL-4-YL) HETSYN 2 Z6V PYRIDIN-4-YL]OXY}PYRIDIN-2-YL)-2-[(PROPAN-2-YL) HETSYN 3 Z6V AMINO]PYRIMIDIN-4(3H)-ONE FORMUL 2 Z6V C23 H25 N7 O2 FORMUL 3 HOH *14(H2 O) HELIX 1 AA1 ASN A 572 GLU A 576 5 5 HELIX 2 AA2 PRO A 578 ASN A 580 5 3 HELIX 3 AA3 HIS A 623 GLY A 641 1 19 HELIX 4 AA4 ASP A 670 LEU A 683 1 14 HELIX 5 AA5 GLU A 751 LYS A 772 1 22 HELIX 6 AA6 ALA A 780 ARG A 782 5 3 HELIX 7 AA7 ASN A 788 HIS A 790 5 3 HELIX 8 AA8 PHE A 797 ARG A 801 5 5 HELIX 9 AA9 ASP A 802 ASP A 806 5 5 HELIX 10 AB1 PRO A 818 MET A 822 5 5 HELIX 11 AB2 ALA A 823 ASP A 829 1 7 HELIX 12 AB3 THR A 833 PHE A 849 1 17 HELIX 13 AB4 ASN A 862 GLY A 872 1 11 HELIX 14 AB5 PRO A 882 TRP A 893 1 12 HELIX 15 AB6 GLU A 896 ARG A 900 5 5 HELIX 16 AB7 THR A 902 GLN A 913 1 12 SHEET 1 AA1 5 LEU A 582 ALA A 590 0 SHEET 2 AA1 5 GLY A 594 LEU A 604 -1 O GLU A 598 N GLY A 585 SHEET 3 AA1 5 ALA A 609 LEU A 618 -1 O VAL A 613 N ALA A 599 SHEET 4 AA1 5 LEU A 660 GLU A 664 -1 O THR A 663 N ALA A 614 SHEET 5 AA1 5 LEU A 649 CYS A 653 -1 N LEU A 650 O ILE A 662 SHEET 1 AA2 2 VAL A 784 LEU A 786 0 SHEET 2 AA2 2 ALA A 792 ILE A 794 -1 O LYS A 793 N LEU A 785 SHEET 1 AA3 2 ILE A 810 VAL A 811 0 SHEET 2 AA3 2 ARG A 816 LEU A 817 -1 O LEU A 817 N ILE A 810 SITE 1 AC1 17 LEU A 588 VAL A 596 ALA A 614 LYS A 616 SITE 2 AC1 17 GLU A 633 MET A 637 LEU A 640 THR A 663 SITE 3 AC1 17 GLU A 664 TYR A 665 CYS A 666 THR A 667 SITE 4 AC1 17 GLY A 669 CYS A 774 LEU A 785 ASP A 796 SITE 5 AC1 17 PHE A 797 CRYST1 61.870 61.870 181.750 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016163 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005502 0.00000